Could presepsin be an alternative marker in the early diagnosis of sepsis in COVID-19?
- Resource Type
- Authors
- Rasime Derya Güleç; Fatma Demet Arslan; Taner Çalışkan; Nimet Şenoǧlu; Nisel Yılmaz; Sabri Atalay; İbrahim Pirim
- Source
- Scandinavian Journal of Clinical and Laboratory Investigation. 82:108-114
- Subject
- C-Reactive Protein
Early Diagnosis
Sepsis
Superinfection
Clinical Biochemistry
Lipopolysaccharide Receptors
COVID-19
Humans
General Medicine
Procalcitonin
Shock, Septic
Biomarkers
Peptide Fragments
- Language
- ISSN
- 1502-7686
0036-5513
In critical patients with Coronavirus Disease (COVID-19), we investigated the diagnostic value of presepsin in the early diagnosis of superinfection with sepsis, and the effect of antibiotic treatment (AT) in the levels of presepsin and procalcitonin and C-reactive protein. A total of 68 critical patients with sepsis and septic shock in the intensive care unit and 20 outpatients (control group) with COVID-19 were taken. ICU patients (